(Q44888513)

7 December 2017

Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma (English)

1 reference

7 December 2017

1 reference

1 reference

P A Reece

1

1 reference

7 December 2017

J F Bishop

2

1 reference

7 December 2017

I N Olver

3

1 reference

7 December 2017

I Stafford

4

1 reference

7 December 2017

B L Hillcoat

5

1 reference

7 December 2017

G Morstyn

6

1 reference

7 December 2017

1 January 1987

1 reference

Cancer Chemotherapy and Pharmacology

7 December 2017

1 reference

7 December 2017

19

1 reference

7 December 2017

4

1 reference

7 December 2017

326-330

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00261482

7 December 2017

0 references

cites work

Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion

1 reference

12 December 2020

Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma

1 reference

12 December 2020

High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine

1 reference

12 December 2020

Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid

1 reference

12 December 2020

Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function

1 reference

12 December 2020

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

12 December 2020

Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer

1 reference

12 December 2020

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

1 reference

12 December 2020

Phase I clinical and pharmacologic trial of carboplatin daily for 5 days

1 reference

12 December 2020

Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II).

1 reference

12 December 2020

Comparison of fitting methods for the analysis of plasma concentration-time data resulting from constant rate intravenous infusion

1 reference

12 December 2020

Phase II trial of carboplatin in non-small cell lung cancer

1 reference

12 December 2020

Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin

1 reference

12 December 2020

Effect of renal function impairment of iproplatin pharmacokinetics and relation to toxicity.

1 reference

12 December 2020

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

1 reference

12 December 2020

Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity

1 reference

12 December 2020

A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00261482

1 reference

7 December 2017

1 reference